Endothelial cells analysis after intravitreal ranibizumab (Lucentis) in age-related macular degeneration treatment: A pilot study

British Journal of Ophthalmology

Volumn 94, Issue 2, 2010, Pages 267-268

  Pérez Rico, Consuelo ^a   Benítez Herreros, Javier ^a   Castro Rebollo, Maria ^a   Gómez SanGil, Yanira ^a   Germain, Francisco ^b   Montes Mollón, María Angeles ^a   Teus, Miguel Ángel ^a  

^a HOSPITAL UNIVERSITARIO PRÍNCIPE DE ASTURIAS   (Spain)

^b UNIVERSITY OF ALCALÁ   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

RANIBIZUMAB;

CELL ASSAY; CELL DENSITY; CELL SIZE; CELL STRUCTURE; CLINICAL ARTICLE; CLINICAL TRIAL; CORNEA ENDOTHELIUM; DRUG MONITORING; ENDOTHELIUM CELL; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; LETTER; MALE; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; SUBRETINAL NEOVASCULARIZATION;

AGED; AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; ENDOTHELIUM, CORNEAL; FEMALE; HUMANS; MACULAR DEGENERATION; MALE; MIDDLE AGED; PILOT PROJECTS; PROSPECTIVE STUDIES;

EID: 76149108445     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjo.2008.153353     Document Type: Letter

References (6)

1. Bakri SJ, Snyder MR, Reid JM, et al. Pharmacokinetics of intravitreal ranibizumab (Lucentis). Ophthalmology 2007;114:2179- 82.
2. Gan L, Fagerholm P, Palmblad J. Vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in the regulation of corneal neovascularization and wound healing. Acta Ophthalmol Scand 2004;82:557-63.
3. Philipp W, Speicher L, Humpel C. Expression of vascular endothelial growth factor and its receptors in inflamed and vascularized human corneas. Invest Ophthalmol Vis Sci 2000;41:2514-22.
4. Yoeruek E, Spitzer MS, Tatar O, et al. Safety profile of bevacizumab on cultured human corneal cells. Cornea 2007;26:977- 82.
5. Ambati BK, Nozaki M, Singh N, et al. Corneal avascularity is due to soluble VEGF receptor-1. Nature 2006;443:993-7.
6. Chiang CC, Chen WL, Lin JM, et al. Effect of bevacizumab on human corneal endothelial cells: a six-month follow-up study. Am J Ophthalmol 2008;146:688-91.